# Sorlandet Hospital HF

Organization · id `cardio:org-sorlandet-hospital-hf` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Sorlandet+Hospital+HF>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other government. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Sorlandet Hospital HF
- Sponsor class: OTHER\_GOV

## Connected pages

- Sponsors: BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function (`cardio:ct-nct03646357`)
- Sponsors: The Southern-Norway Post-Stroke Atrial Fibrillation Study (`cardio:ct-nct07407790`)
- Sponsors: Digital Long-term Follow-up of Patients With Coronary Artery Disease (`cardio:ct-nct07720349`)

## Provenance

Content hash: 831016fb9213b5dcd5f45243069ad1b70ceb5fa3001ff55e3d9d979c46fe22f1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
